IGXT Stock, Intelgenx Techs Corp Information
Stock Information
Get IGXT Alerts
News, Short Squeeze, Breakout and More Instantly...
About Intelgenx Techs Corp
IntelGenx is a leading drug delivery company focused on the development of innovative products based on its proprietary oral drug delivery technologies. Established in , the Montreal based company develops innovative oral drug delivery solutions based on its proprietary platform technologies, VersaFilmTM, VersaTabTM and AdVersaTM. IntelGenx has developed a broad and diverse product portfolio addressing unmet market needs and offering lifecycle management opportunities. Forfivo XLTM, launched in , is the first and only FDA approved once daily bupropion HCl mg dose in a single tablet for the treatment of major depressive disorder. IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R amp D, clinical monitoring, IP protection, analytical method development and regulatory services. IntelGenx state of the art manufacturing facility, established for the VersaFilmTM technology platform, supports lab scale to pilot and commercial scale production, offering full service capabilities to our clients. IntelGenx Technologies Corp. is listed on the TSX V and OTC QX, More information is available about the company at: www.intelgenx.com.